USPTO 2015–2025 USPTO PatentsView US Corporation

Bard Shannon Limited

USPTO PatentsView assignee record - 26 granted patents across 4 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Bard ranks #11,565 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 4 technology areas.

#11,565
of 49,997 US assignees by volume
Top 15%
by Innovation Score (49.4/100)
18.2
avg claims per patent
+60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11565 · US Corporation #11,565 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 26 grants
  • UPPER-Q #11,565/49,997
  • PHOTO-FINISH Baumueller Nuernberg
  • CPC-NARROW A61F · 4 areas
  • INNOV-PAR 49.4/100
  • CLAIMS-RICH 18.2 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +60% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Baumueller Nuernberg GmbH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bard’s 49.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Bard

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Bard's Innovation Score is 49.4/100 (top 15% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Bard?

Each dot is one of Bard’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bard’s own 18.2 claims/patent is ABOVE the 16.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bard vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 25.92626.1 510152025 Granted patents (volume) Avg claims / patent Bolt Threads, Inc. - 26, 20.23Bolt ThreadsBraemar Manufacturing, LLC - 26, 19.15Braemar Manufactu…Bristol, Inc - 26, 22BristolBullfrog International, LC - 26, 15.58Bullfrog Internat…Baumueller Nuernberg GmbH - 26, 10.15Baumueller Nuernb…Belden Inc. - 26, 23.42BeldenBio-Rad Europe GmbH - 26, 13.08Bio-rad EuropeBioSig Technologies, Inc. - 26, 16.77BiosigBard Shannon Limited - 26, 18.23Bard Shannon
Bard vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bard's grants concentrate

Bard Shannon Limited is a focused PatentsView assignee: 4 CPC subclasses with 80.8% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2023 (8 grants) versus a trough of 1 in 2019. By volume, Bard sits between Bolt Threads, Inc. and BioSig Technologies, Inc..

Bard's three-year grant acceleration

Bard Shannon Limited shows 13 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Bard's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Bard holds 26 patents at rank #11,576, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Bard

By rank, the assignees closest to #11,576 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Bard's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bard, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Bard ranks #308 of 3,082 assignees by patent count in that subclass.

Bard's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 15% higher than 85% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0246810 201520162017201820192020202120232024 5
USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Bard Shannon Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 7.7%
2016 2 7.7%
2017 2 7.7%
2018 3 11.5%
2019 1 3.8%
2020 2 7.7%
2021 1 3.8%
2023 8 30.8%
2024 5 19.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Bard Shannon Limited's patent record in context - here's where to go next.

  • Bard Shannon Limited's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 80.8% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #11,565 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Bard Shannon Limited against Bolt Threads, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 49.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.